“Look, in the end, it could have been a lot worse in terms of timing and the impact,” incoming CEO Michael Michaud said on a conference call on Wednesday. “We still believe in the potential of the asset. This is the reason why I joined Red Pine, this is reason why I’m here today and am looking forward to becoming the CEO.”
The scandal for the junior, which lost 60% of its share price when assay discrepancies were first revealed on May 1, may bring to mind the Bre-X Minerals fraud of the 1990s, but is on a much lower scale. Red Pine estimates the doctored assays aimed to marginally increase grade and could lower its Wawa project resource by as much as 12%. Bre-X involved blatant salting of core samples with incompatible gold nuggets.
“Certainly, though there was some manipulation of the assets, they were mostly embellishments,” Michaud said. “I’m not really terribly upset about the 10 or 15% because we’ll get…
